Pharma Journalist -

Samumed LLC has entered an exclusive license agreement with United Therapeutics Corporation for North American rights to Samumed's SM04646, being developed for the treatment of…
Read More...

CRISPR Therapeutics and ViaCyte announced a collaboration focused on the discovery, development, and commercialization of gene-edited allogeneic stem cell therapies for the treatment of…
Read More...

LEO Pharma A/S and MorphoSys AG announced an expansion of their existing strategic alliance to include peptide-derived therapeutics. The objective of the alliance is to identify novel,…
Read More...

SMi Group Reports: The official agenda and highlights for the 3rd annual conference, which is taking place on the 12th and 13th November 2018 in Iselin, New Jersey, has been released.…
Read More...

Asia Pacific has always been at the forefront of consumer probiotics and has some of the most exciting markets for fermented and probiotic skincare. When L’Oréal announced their FY 2018…
Read More...

Allergan plc announced it has agreed to acquire Bonti, Inc., a privately held clinical-stage biotechnology company focused on the development and commercialization of novel, fast-acting…
Read More...

Sanofi will change the organizational structure of two of its Global Business Units (GBU) to provide greater focus on its operations in mature markets and across emerging markets.…
Read More...

PMI BioPharma Solutions officially formed in January of 2018, has established complete research and manufacturing operations at multiple sites located in both Nashville and Celina…
Read More...

Recipharm has successfully received European Medicines Verification Organisation (EMVO) approval to submit serialisation data to the European Hub. The connection, which was…
Read More...

Paragon BioTeck, a privately held pharmaceutical and medical device company specializing in the development and commercialization of ophthalmic pharmaceuticals, devices and therapies,…
Read More...